Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
Bavarian Nordic halts cancer vaccine program
Bavarian Nordic may be celebrating its most profitable year yet, but that hasn’t stopped the Danish biotech from streamlining its portfolio.
James Waldron
Feb 21, 2024 7:25am
Everest to continue mRNA ascent alone, ending Providence collab
Feb 20, 2024 8:19am
Valneva sells priority review voucher for $103M, R&D to benefit
Feb 5, 2024 9:15am
Saudi Arabia sets sights on becoming a biotech hub
Jan 25, 2024 10:38am
Would you eat a lollipop without candy? The flu virus won't
Jan 16, 2024 9:02am
CureVac touts COVID-19 vax data despite adverse events
Jan 5, 2024 11:16am